We assign a technical rating of 0 out of 10 to BFRA. BFRA scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
The long term trend is still negative, but the short term trend is neutral. It is advised to wait a little bit longer to see how this turns out.
When comparing the yearly performance of all stocks, BFRA is a bad performer in the overall market: 85% of all stocks are doing better.
BFRA is currently trading in the lower part of its 52 week range. The S&P500 Index however is trading in the upper part of its 52 week range, so BFRA is lagging the market.
Warning: BFRA has an average volume of 28721 traded shares per day. This is quite low and it might be dangerous to invest in illiquid stocks.
BFRA is part of the Biotechnology industry. There are 562 other stocks in this industry, BFRA did better than 62% of them.
In the last month BFRA has a been trading in the 2.09 - 3.68 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.
Considerably lower volume is observed in the last couple of days.